Results 171 to 180 of about 17,663 (255)

Over 10 years of non-vitamin K antagonist oral anticoagulants: highlights, challenges, and future developments. [PDF]

Eur Heart J Suppl
De Caterina R, Chiusolo S.
europepmc   +1 more source

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study. [PDF]

Int J Cardiol Heart Vasc, 2023
Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L.   +4 more
europepmc   +1 more source

Corrigendum to: Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management. [PDF]

Interv Cardiol
Izraiq M, Alshoubaki N, Abu-Dhaim OA, Al-Qalalweh S, Aqel R.   +4 more
europepmc   +1 more source

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation. [PDF]

PLoS One, 2022
Choi SH, Kim M, Kim H, Kim DH, Baek YS.
europepmc   +1 more source

Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation. [PDF]

ANZ J Surg
Chang S, Lombardo A, Smith I, Lawler S, He C, Stroebel A.   +5 more
europepmc   +1 more source

Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial. [PDF]

Stroke, 2023
Polymeris AA, Karwacki GM, Siepen BM, Schaedelin S, Tsakiris DA, Stippich C, Guzman R, Nickel CH, Sprigg N, Kägi G, Vehoff J, Barinka F, Thilemann S, Maurer M, Wagner B, Traenka C, Gensicke H, De Marchis GM, Bonati LH, Fischer U, Z'Graggen WJ, Nedeltchev K, Wegener S, Baumgartner P, Engelter ST, Seiffge DJ, Peters N, Lyrer PA, TICH-NOAC Investigators.   +28 more
europepmc   +1 more source

Reporting quality of randomized-controlled trials exploring the efficacy and safety of new anticoagulants in acute venous thromboembolism or pulmonary embolism, based on CONSORT statement [PDF]

, 2015
Ντόντου, Δήμητρα
core   +1 more source

Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis. [PDF]

Cochrane Database Syst Rev
Al Said S, Kaier K, Nury E, Alsaid D, Gibson CM, Bax J, Westermann D, Meerpohl JJ.   +7 more
europepmc   +1 more source

Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation. [PDF]

EuroIntervention, 2023
Mangner N, Brinkert M, Keller LS, Moriyama N, Hagemeyer D, Haussig S, Crusius L, Kobza R, Abdel-Wahab M, Laine M, Stortecky S, Pilgrim T, Nietlispach F, Ruschitzka F, Thiele H, Toggweiler S, Linke A.   +16 more
europepmc   +1 more source

Efficacy and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta-analysis of controlled randomized trials. [PDF]

J Arrhythm
Chang TY, Chan YH, Chao TF, Lin CY, Lin YJ, Chang SL, Lo LW, Hu YF, Chung FP, Chen SA.   +9 more
europepmc   +1 more source